Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

EMPAGLIFLOZIN AND DAPAGLIFLOZIN IN IMPROVING EJECTION FRACTION: A PROSPECTIVE OBSERVATIONAL COMPARISON OF CLINICAL OUTCOMES AND PATIENT REPORTED QUALITY OF LIFE

Background: SGLT2 inhibitors have transformed heart failure treatment, especially empagliflozin and dapagliflozin. Although both have proven cardiovascular benefits in clinical trials, there is little data comparing them in real-world settings. This study aims to address that by comparing their effects on heart functio...

C. Bhargava, M. Daisy, Joyce Sharon et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.